Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes
Clinical trial NCT01235260 · COMPLETED
Trial details
- NCT number
- NCT01235260
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.